Glen Weiss, MD
STORM Therapeutics · Bantam Pharmaceuticals · Medical Lead
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Glen Weiss, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:54 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07906093 · Expanded Access Program to Provide STC-15 to Patients With Selected Advanced CancerSTORM Therapeutics LTD · available · Cancer · study director
- Ph1NCT06792734 · Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell LymphomasBantam Pharmaceuticals · recruiting · Lymphoma, B-Cell · study director
- Ph1NCT06440005 · A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsAngiex, Inc. · recruiting · Cancer, Advanced Cancer, Locally Advanced Carcinoma · study director
- Ph1NCT03680560 · Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor CancersCogent Biosciences, Inc. · terminated · Solid Tumor, HER-2 Protein Overexpression · study director
- N/ANCT02297087 · Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for TreatmentWestern Regional Medical Center · terminated · Small Cell Lung Cancer · principal investigator
- Ph2NCT01860040 · Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung CancerWestern Regional Medical Center · terminated · Non-squamous Cell Non-Metastatic Non-Small Cell Lung Cancer, Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT01011439 · Phase II Study Of Oral PHA-848125AC In Patients With Thymic CarcinomaTiziana Life Sciences LTD · terminated · Thymic Carcinoma · principal investigator
- Ph1NCT00495144 · A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid TumorsThreshold Pharmaceuticals · completed · Tumors, Hypoxia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.